Paswan Shravan Kumar, Gautam Arti, Verma Pritt, Rao Chandana Venkateswara, Sidhu Om Prakash, Singh Ajeet Pratap, Srivastava Sajal
Department of Pharmacognosy & Ethnopharmacology, National Botanical Research Institute (CSIR), U.P., Lucknow, India.
Amity Institute of Pharmacy, Amity University, Lucknow, India.
J Pharmacopuncture. 2017 Jun;20(2):93-99. doi: 10.3831/KPI.2017.20.012. Epub 2017 Jun 30.
s L. (family: Selaginaceae), is often used in traditional Indian systems of medicine for the prevention and cure of several disorders and for the treatment of patient with spermatorrhoea, venereal disease, constipation, colitis, urinary tract infections, fever, epilepsy, leucorrhoea, beri-beri and cancer. It is also used as a strength tonic. This study aimed to evaluate the mechanisms underlying the anti-inflammatory effects of topically administered aqueous, polar and non-polar methanolic fractions (10 mg/20 μL) of .
An acute oral toxicity study of at doses from 250 to 2,000 mg/kg body weight (bw) was performed. Aqueous, polar and non-polar methanolic extracts (10 mg/20 μL) applied topically for 5 days were evaluated for their anti-inflammatory effects against 12-tetra-O-decanoyl phorbol acetate (TPA)-induced inflammation by using the redness in the ear, the ear's weight (edema), oxidative stress parameters, such as lipid-peroxide (LPO) and nitric oxide (NO), and the pro-inflammatory cytokines involved in inflammation, such as tumour necrosis factor (TNF)-, interleukin (IL)-1 and IL-6. Indomethacine (0.5 mg/20 μL) was used for the positive control.
produced no mortalities when administered orally at doses from 250 to 2,000 mg/kg bw. Topical treatment with the non-polar methanolic fraction (10 mg/20 L) significantly suppressed redness (2.4 ± 0.5) and edema (30.4 ± 1) and effectively reduced the LPO level (32.3 ± 3.3). The NO level was (8.07 ± 0.55), and the TNF-, IL-1, and IL-6 levels were decreased to 69.6 ± 15.5, 7.7 ± 4.8 and 82.6 ± 5.9, respectively.
This study demonstrated for the first time the mechanisms underlying the anti-inflammatory effect of medicinal plants like and quantified the pharmacological interactions between them. The present study showed this herbal product to be a promising anti-inflammatory phytomedicine for the treatment of patients with inflammatory skin diseases.
卷柏(卷柏科)常用于印度传统医学体系,用于预防和治疗多种疾病,以及治疗遗精、性病、便秘、结肠炎、尿路感染、发热、癫痫、白带、脚气病和癌症患者。它还用作强身滋补剂。本研究旨在评估局部应用卷柏的水相、极性和非极性甲醇提取物(10毫克/20微升)抗炎作用的潜在机制。
进行了卷柏在250至2000毫克/千克体重剂量下的急性经口毒性研究。通过测量耳红、耳重(水肿)、氧化应激参数如脂质过氧化物(LPO)和一氧化氮(NO)以及参与炎症的促炎细胞因子如肿瘤坏死因子(TNF)-α、白细胞介素(IL)-1和IL-6,评估局部应用5天的水相、极性和非极性甲醇提取物(10毫克/20微升)对12-O-十四酰佛波醇-13-乙酸酯(TPA)诱导炎症的抗炎作用。吲哚美辛(0.5毫克/20微升)用作阳性对照。
卷柏在250至2000毫克/千克体重剂量经口给药时未导致死亡。局部用非极性甲醇提取物(10毫克/20微升)治疗可显著抑制耳红(2.4±0.5)和水肿(30.4±1),并有效降低LPO水平(32.3±3.3)。NO水平为(8.07±0.55),TNF-α、IL-1和IL-6水平分别降至69.6±15.5、7.7±4.8和82.6±5.9。
本研究首次证明了卷柏等药用植物抗炎作用的潜在机制,并对它们之间的药理相互作用进行了量化。本研究表明这种草药产品是一种有前景的抗炎植物药,可用于治疗炎症性皮肤病患者。